[logo] HealthTree Foundation
more_vert

Education, community and tools to navigate your disease

Lifetime support and education

Your brighter tomorrow starts today with free patient education resources

Learn more with 101 patient guides

Meaningful patient-to-patient connections

Find a community of multiple myeloma patients who care and are just like you

Doug Keller image
HealthTree Coach Icon

Doug Keller

multiple myeloma coach since 2021

I was diagnosed in 2012 after I fell at my son's college graduation and broke my arm, which had a plasmacytoma in it. After radiation and induction therapy I had a stem cell transplant in 2013. Subsequently I was on various combinations of Revlimid, Elotuzumab, Daratumumab, Pomalyst, Kyprolis, and dexamethasone. I tried a clinical trial that was not successful for me and then had another SCT in 2020. After a year I relapsed again and had Carvykti CAR-T therapy in June, 2022. I was in remission for the first time, and stayed in remission for 28 months. Since relapsing in late 2024 I've been on bispecific antibodies, first teclistamab (Tecvayli) and now talquetamab (Talvey), with mixed success. I worked for 22 years in pharmaceutical research and was involved in the development of Sarclisa, which was personally very satisfying. I retired in January 2021. My wife is happy to have me doing things around the house and showing less stress. She has been a rock of support during this whole process, and my two sons are also very supportive. My quality of life is very good, and I have been enjoying getting back on the golf course now that I have time to play. I am also informally mentoring friends who have smoldering myeloma. In 2022 I had Carvykti CAR-T and went into remission for 28 months. I went back on treatment with teclistamab, which didn't work, and now talquetamab. Talquetamab alone didn't work, but in combination with lenalidomide it worked extremely well.

View Coach

Powerful Patient Data Portal

HealthTree Cure Hub helps you navigate your disease by tracking your labs and so much more

HealthTree Cure Hub Program demo image

You can help advance multiple myeloma research

In HealthTree Cure Hub, your data and researchers' expertise combine to shorten the breakthrough time from years to days; every second counts

HealthTree Cure Hub Surveys demo image

Get involved today!

At HealthTree we're on a mission to accelerate cures. Here's how you can help:

Join a local chapter

Our chapters are designed to empower and activate patients and caregivers who are committed to finding a cure. In partnership with HealthTree, chapters provide support, education, and raise revenue to cure diseases

Find a community arrow_forward

Donate to HealthTree, a nonprofit organization

Our core mission is to provide as many patient resources possible to any and all underserved communities in the US and eventually worldwide.

Donate to HealthTree arrow_forward

Thank you to our multiple myeloma funding partners

Free patient resources made possible with

Amgen logo
Adaptive logo
Kite logo

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.